Reactive oxygen species (ROS) produced naturally during cellular metabolism often cause oxidative damage to cells. However, these molecules also play an important role in normal cellular signaling.

Hutchmed receives China NMPA conditional approval for Orpathys to treat gastric cancer patients with MET amplification: Hong Kong, Shanghai Saturday, July 4, 2026, 11:00 Hrs [IST] ...

AstraZeneca's selective MET inhibitor Orpathys has won conditional approval in China for a new indication in MET-amplified ...

QRX003 Holds Orphan Drug Designation in the United States, the European Union, and Japan, Plus Fast Track and Rare Pediatric Disease Designations ...

Measles elimination status in the United States is over in practice, CIDRAP infectious disease experts declared June 24, ...

A new pancreatic cancer drug doubles survival times. And a new treatment for a rare form of ALS slows and improves some ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 02, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; ...

Detailed price information for Medexus Pharms Inc (MEDXF) from The Globe and Mail including charting and trades.

If there was a laboratory for the new authoritarianism, it was Hungary under ex-Prime Minister Viktor Orbán. Orbán did not ...

Zemcelpro® (dorocubicel), also known as UM171 Cell Therapy, recently received conditional marketing authorisation in Europe from the European Commission ...

The careful phrasing is everywhere you look. The United States "may lose” its measles elimination status. The country's ...

Zemcelpro is a novel personalized cryopreserved hematopoietic stem cell transplantation product containing two components, namely UM171-expanded CD34+ cells (dorocubicel) and unexpanded CD34- cells, e ...